Physician profile
Jeffery L Greski
NPI 1073619441
$5,708.14
in general payments reported to CMS, 2019-2025
43 companies · $914 in 2025
The $914 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $669 · 2021: $768 · 2022: $676 · 2023: $1,014 · 2024: $824 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,751.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $847.44 | 2019-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $695.22 | 2023-2025 | Orgovyx, Gemtesa |
| Axonics, INC. | $372.37 | 2020-2023 | Bulkamid, Axonics |
| Merck Sharp & Dohme LLC | $267.32 | 2019-2025 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $229.71 | 2019-2023 | Xiaflex |
| Blue Earth Diagnostics | $214.94 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $211.98 | 2019-2022 | |
| Pfizer INC. | $208.28 | 2019-2025 | |
| 180 Medical, INC. | $205.42 | 2020-2025 | Gentlecath |
| Antares Pharma, INC. | $192.94 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Allergan, INC. | $188.03 | 2019-2022 | |
| Medtronic USA, INC. | $169.47 | 2019-2020 | |
| Janssen Biotech, INC. | $163.65 | 2023-2025 | Erleada |
| Medtronic, INC. | $162.83 | 2021-2024 | Interstim |
| Urogen Pharma, INC. | $137.65 | 2024-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $114.11 | 2019-2025 | |
| Hologic Sales and Service, LLC | $112.42 | 2025 | Myosure Tissue Removal Device |
| Boston Scientific Corporation | $111.89 | 2021-2023 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $105.88 | 2022-2025 | Prolaris, Myrisk |
| Halozyme INC | $99.02 | 2023 | |
| Olympus America INC. | $98.05 | 2021-2025 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $83.15 | 2020-2025 | Personal Catheter Intermittent Catheter |
| Dendreon Pharmaceuticals LLC | $79.56 | 2024 | Provenge |
| Ferring Pharmaceuticals INC. | $65.39 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $53.15 | 2022 | |
| Laborie Medical Technologies Corp. | $53.04 | 2023-2024 | Endosheath Technology |
| Abbvie INC. | $47.60 | 2022-2024 | |
| Neotract INC. | $44.12 | 2020 | |
| Verity Pharmaceuticals INC. | $43.09 | 2025 | Trelstar |
| Teleflex LLC | $41.22 | 2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $32.49 | 2019 | |
| Urovant Sciences INC | $31.28 | 2021-2022 | |
| Dentsply Ih INC. | $29.85 | 2021 | |
| Calyxo, INC. | $26.44 | 2025 | Cvac Aspiration System |
| Acerus Pharmaceuticals Corporation | $24.93 | 2021 | |
| Cook Medical LLC | $24.36 | 2019-2021 | |
| Procept Biorobotics Corporation | $23.77 | 2024 | Aquabeam System |
| Endo USA, INC. | $20.30 | 2024 | Xiaflex |
| Agiliti Surgical, INC. | $18.37 | 2020 | |
| Dentsply Ih Ab | $16.30 | 2024 | Lofric |
| Astrazeneca Pharmaceuticals LP | $14.86 | 2025 | Lynparza |
| Alnylam Pharmaceuticals INC. | $13.84 | 2023 | Oxlumo |
| Eisai INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Greski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.